Bull Market Won't B...
Health Care: Drugs
Marshall Edwards Inc. (MSHL: )
$0.40 0.01 | 3.13%
07/03/12 - 11:07 AM ET
TheStreet Ratings Grade for MSHL
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.00 | 1.00 | 1.00 | 1.00 |
Portfolios with MSHL
- Portfolio NameUser Type
- Contributor5 Drug Stock Losers of 2010
- Userjbryant
- UserLast Day of the JPMorgan He...
- UserPART 7 JPMorgan 26th Annual...
- UserBarron's Activist Stocks 11...
- UserJim G Portfolio 1
- UserTom McCamant Portfolio 1
- Userjbc Portfolio 1
Latest MSHL Headlines from TheStreet
- 5 Drug Stock Losers of 2010 12.06.10 | 07:12 am
- Mediacom, Jones Soda: Midday Volume Plays 06.01.10 | 10:06 am
Press Releases for MSHL
- Marshall Edwards Announces Name Change To MEI Pharma ("MEIP") - PR Newswire 06.28.12 | 09:06 am
- Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143 - PR Newswire 06.04.12 | 09:06 am
- Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344 - PR Newswire 05.29.12 | 09:05 am
- Marshall Edwards Receives FDA Approval Of Investigational New Drug Application For Clinical Testing Of Oncology Drug Candidate ME-344 - PR Newswire 04.10.12 | 09:04 am
- Marshall Edwards Announces Data From Clinical Trial Of ME-143 Selected For Presentation At ASCO Annual Meeting - PR Newswire 04.03.12 | 09:04 am
- Marshall Edwards CEO To Present At Needham Healthcare Conference - PR Newswire 03.28.12 | 09:03 am
- Marshall Edwards Receives Notice Of Effectiveness For Rights Offering To Stockholders - PR Newswire 03.27.12 | 09:03 am
- Marshall Edwards Announces Terms For Rights Offering To Stockholders - PR Newswire 03.19.12 | 09:03 am
- Marshall Edwards Submits Investigational New Drug Application For Oncology Drug Candidate ME-344 - PR Newswire 03.06.12 | 09:03 am
- Marshall Edwards CEO To Present At Roth Capital Partners Growth Stock Conference - PR Newswire 02.29.12 | 09:02 am
Partner Headlines for MSHL
- Morning Market Movers - Benzinga 12.20.11 | 09:12 am
- Marshall Edwards Taking Big Pharma Clinical Path - Seeking Alpha 09.29.11 | 06:09 am
- Morning Market Movers - Benzinga 09.08.11 | 09:09 am
- Stocks Struggle Amid European Worries, Weak Housing Report; Commodities Mixed - NASDAQ 08.16.11 | 04:08 pm
- Mid-Day Update: Stocks Pare Some Losses But Remain in Red; Europe in Spotlight - NASDAQ 08.16.11 | 04:08 pm
- Morning Market Movers - Benzinga 08.16.11 | 09:08 am
- A Look at 5 Stocks in the Green Wednesday - Seeking Alpha 07.28.11 | 09:07 am
- Top Buy and Sell Ideas Based on Wednesday's Biggest Gainers - Seeking Alpha 07.28.11 | 09:07 am
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 1 - Reuters 06.01.10 | 01:06 pm
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on June 1 - Reuters 06.01.10 | 10:06 am
